AC
ZBH icon

Allstate Corporation’s Zimmer Biomet ZBH Stock Holding History

Allstate Corporation’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Buy
41,929
+15,801
+60% +$1.39M 0.04% 293
2026
Q1 		$2.36M Buy
26,128
+12,002
+85% +$1.1M 0.03% 453
2025
Q4 		$1.27M Buy
14,126
+7,052
+100% +$669K 0.02% 473
2025
Q3 		$697K Buy
+7,074
New +$701K 0.02% 452
2025
Q2 		– Sell
-7,537
Closed -$853K – 576
2025
Q1 		$853K Buy
7,537
+1,208
+19% +$129K 0.03% 380
2024
Q4 		$669K Buy
+6,329
New +$679K 0.02% 403
2023
Q1 		– Sell
-9,663
Closed -$1.23M – 565
2022
Q4 		$1.23M Hold
9,663
– – 0.04% 303
2022
Q3 		$1.01M Sell
9,663
-1,148
-11% -$126K 0.03% 334
2022
Q2 		$1.14M Sell
10,811
-736
-6% -$87.3K 0.04% 309
2022
Q1 		$1.48M Buy
11,547
+5,048
+78% +$608K 0.04% 316
2021
Q4 		$802K Buy
6,499
+516
+9% +$67.5K 0.02% 578
2021
Q3 		$850K Sell
5,983
-697
-10% -$103K 0.04% 332
2021
Q2 		$1.04M Sell
6,680
-619
-8% -$100K 0.04% 294
2021
Q1 		$1.13M Buy
7,299
+785
+12% +$122K 0.04% 287
2020
Q4 		$974K Sell
6,514
-673
-9% -$95.1K 0.03% 292
2020
Q3 		$950K Sell
7,187
-399
-5% -$52.1K 0.03% 260
2020
Q2 		$879K Buy
7,586
+1,086
+17% +$125K 0.03% 283
2020
Q1 		$638K Sell
6,500
-8,220
-56% -$1.08M 0.03% 304
2019
Q4 		$2.14M Buy
14,720
+61
+0.4% +$8.42K 0.04% 283
2019
Q3 		$1.95M Sell
14,659
-211
-1% -$27.3K 0.03% 291
2019
Q2 		$1.7M Buy
14,870
+1,852
+14% +$217K 0.03% 304
2019
Q1 		$1.61M Sell
13,018
-1,740
-12% -$198K 0.04% 256
2018
Q4 		$1.49M Buy
+14,758
New +$1.66M 0.05% 246

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allstate Corporation's ZBH Position: Q2 2026 in Review

Allstate Corporation increased its Zimmer Biomet (ZBH) stake by 60% in Q2 2026, buying an estimated $1.39M and bringing the position to 41,929 shares worth $3.61M. The position accounts for 0.04% of the portfolio, ranked #293.

Allstate Corporation first reported a position in ZBH in Q4 2018 and has held it in 23 quarters since. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Allstate Corporation held 41,929 shares of Zimmer Biomet worth $3.61M as of Q2 2026.
  • Allstate Corporation bought 15,801 Zimmer Biomet shares in Q2 2026, an estimated $1.39M.
  • Zimmer Biomet made up 0.04% of Allstate Corporation's portfolio in Q2 2026, its #293 holding.
  • Allstate Corporation first reported a position in Zimmer Biomet in Q4 2018 and has held it in 23 quarters since.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.